Antitrust in the Pharmaceutical Sector: An Overview of U.S. Case Law
e-Competitions Bulletin, No. 88026, Nov. 2018
10 Pages Posted: 11 Nov 2018
Date Written: October 18, 2018
In this overview, I summarize pharmaceutical antitrust law in the US and EU on settlements, product hopping, sample denials, citizen petitions, and rebates/bundling.
Keywords: Pharmaceutical, Antitrust, Settlements, Product Hopping, Sample Denials, Citizen Petitions, Rebates/Bundling
JEL Classification: I18, K21, L40, L41, L43, L65, O34, O38
Suggested Citation: Suggested Citation